Strategic Investment Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Buy |
8,749
+3,148
| +56% | +$902K | 0.24% | 51 |
|
|
2025
Q1 | $1.73M | Sell |
5,601
-382
| -6% | -$118K | 0.18% | 73 |
|
|
2024
Q4 | $2.11M | Buy |
5,983
+95
| +2% | +$33.5K | 0.22% | 56 |
|
|
2024
Q3 | $2.11M | Buy |
5,888
+4,034
| +218% | +$1.45M | 0.23% | 61 |
|
|
2024
Q2 | $591K | Sell |
1,854
-123
| -6% | -$39.2K | 0.07% | 160 |
|
|
2024
Q1 | $454K | Buy |
1,977
+118
| +6% | +$27.1K | 0.06% | 182 |
|
|
2023
Q4 | $409K | Sell |
1,859
-92
| -5% | -$20.2K | 0.06% | 183 |
|
|
2023
Q3 | $441K | Buy |
1,951
+37
| +2% | +$8.36K | 0.07% | 179 |
|
|
2023
Q2 | $423K | Buy |
1,914
+198
| +12% | +$43.7K | 0.06% | 145 |
|
|
2023
Q1 | $384K | Buy |
1,716
+661
| +63% | +$148K | 0.07% | 179 |
|
|
2022
Q4 | $293K | Buy |
+1,055
| New | +$293K | 0.06% | 192 |
|